Search Results - "de Veer, M. J."

Functional classification of interferon-stimulated genes identified using microarrays by de Veer, Michael J., Holko, Michelle, Frevel, Mathias, Walker, Eldon, Der, Sandy, Paranjape, Jayashree M., Silverman, Robert H., Williams, Bryan R. G.

“…Interferons (IFNs) are a family of multifunctional cytokines thatactivate transcription of subsets of genes. The gene products inducedby IFNs are responsible…”
Get full text

Stimulation of innate immune responses by malarial glycosylphosphatidylinositol via pattern recognition receptors by Nebl, T, De Veer, M J, Schofield, L

“…The glycosylphosphatidylinositol (GPI) anchor of Plasmodium falciparum is thought to function as a critical toxin that contributes to severe malarial…”
Get more information

Field vaccination of sheep with a larval-specific antigen of the gastrointestinal nematode, Haemonchus contortus , confers significant protection against an experimental challenge infection by Piedrafita, D.P, de Veer, M.J, Sherrard, J, Kraska, T, Elhay, M, Meeusen, E.N

“…Highlights ► Sheep were vaccinated on pasture with a larval-specific antigen. ► Only two immunizations using an approved adjuvant were administered. ►…”
Get full text

IFI60/ISG60/IFIT4, a New Member of the Human IFI54/IFIT2 Family of Interferon-Stimulated Genes by de Veer, M.J., Sim, H., Whisstock, J.C., Devenish, R.J., Ralph, S.J.

“…We report the cloning and sequencing of a full-length cDNA encoding a new member of the human IFI54 (HGMW-approved symbol IFIT2) gene family, designated IFI60…”
Get full text

The adjuvant system AS01 up‐regulates neutrophil CD14 expression and neutrophil‐associated antigen transport in the local lymphatic network by Neeland, M. R., Shi, W., Collignon, C., Meeusen, E. N. T., Didierlaurent, A. M., de Veer, M. J.

“…Summary The liposome‐based adjuvant system AS01 is under evaluation for use in several vaccines in clinical development. We have shown previously that AS01…”
Get full text

How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018 by de Veer, A. J. W. M., Bennaghmouch, N., Dewilde, W. J. M., ten Berg, J. M.

“…Background Antithrombotic treatment choices are complicated when patients have both atrial fibrillation (AF) and acute coronary syndrome and/or undergo…”
Get full text

First report of a comparative patient-oriented perspective on the use of non-vitamin-K oral anticoagulants or vitamin-K antagonists in atrial fibrillation: patients’ experiences, side-effects and practical problems leading to non-adherence by Bennaghmouch, N., de Veer, A. J. W. M., Zivelonghi, C., van Dijk, L., ten Berg, J. M.

“…Background Non-vitamin‑K oral anticoagulants (NOACs) are recommended as the first-choice therapy for stroke prevention in patients with non-valvular atrial…”
Get full text

Correction to: First report of a comparative patient-oriented perspective on the use of non-vitamin-K oral anticoagulants or vitamin-K antagonists in atrial fibrillation: patients’ experiences, side-effects and practical problems leading to non-adherence by Bennaghmouch, N., de Veer, A. J. W. M., Zivelonghi, C., van Dijk, L., ten Berg, J. M.

“…A Correction to this paper has been published: https://doi.org/10.1007/s12471-019-01331-x…”
Get full text

Management and outcomes of real-world use of non-vitamin-K oral anticoagulants (NOACs) in patients with atrial fibrillation: experience of a dedicated NOAC clinic by de Veer, A. J. W. M., Bennaghmouch, N., Wijffels, M. C. E. F., ten Berg, J. M.

“…Background Current guidelines recommend non-vitamin‑K oral anticoagulants (NOACs) as the first-choice therapy for stroke prevention in patients with atrial…”
Get full text

Activation of the interferon system by short-interfering RNAs by Williams, Bryan R.G, Sledz, Carol A, Holko, Michelle, de Veer, Michael J, Silverman, Robert H

“…RNA interference (RNAi) is a powerful tool used to manipulate gene expression or determine gene function. One technique of expressing the short double-stranded…”
Get full text

Efficacy and Safety of the Use of Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials by Bennaghmouch, Naoual, de Veer, Anne J.W.M, Bode, Kerstin, Mahmoodi, Bakhtawar K, Dewilde, Willem J.M, Lip, Gregory Y.H, Brueckmann, Martina, Kleine, Eva, ten Berg, Jurriën M

“…BACKGROUND:Current guidelines recommend non–vitamin K antagonist oral anticoagulants (NOACs) as the first-choice therapy in patients with nonvalvular atrial…”
Get full text

Response by de Veer et al to Letter Regarding Article, “Efficacy and Safety of the Use of Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials” by de Veer, Anne J.W.M, Bennaghmouch, Naoual, Mahmoodi, Bakhtawar K, ten Berg, Jurriën M

Get full text

innate host defence against nematode parasites by DE VEER, M.J, KEMP, J.M, MEEUSEN, E.N.T

“…Nematode parasites cause significant infections in both humans and animals. They are complex, multicellular organisms that present unique challenges for the…”
Get full text

The WOEST 2 registry: A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention by de Veer, A. J. W. M., Bennaghmouch, N., Bor, W. L., Herrman, J. P. R., Vrolix, M., Meuwissen, M., Vandendriessche, T., Adriaenssens, T., de Bruyne, B., Magro, M., Dewilde, W. J. M, ten Berg, J. M.

“…Background Patients on oral anticoagulants (OACs) undergoing percutaneous coronary intervention (PCI) also require aspirin and a P2Y12 inhibitor (triple…”
Get full text

Economic evaluation of the use of non-vitamin K oral anticoagulants in patients with atrial fibrillation on antiplatelet therapy: a modelling analysis using the healthcare system in the Netherlands by Bennaghmouch, Naoual, de Veer, Anne J W M, Mahmoodi, Bakhtawar K, Jofre-Bonet, Mireia, Lip, Gregory Y H, Bode, Kerstin, ten Berg, Jurriën M

“…Abstract Aims Non-vitamin K oral anticoagulants (NOACs) have consistently demonstrated superior efficacy in terms of stroke prevention and safety in terms of…”
Get full text

Interferon- and virus-inducible gene ISG-60. Map position 10q23.3 by Baker, E, de Veer, M J, Devenish, R J, Sutherland, G R, Ralph, S J

Get full text

MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll‐like receptor 2 signaling by de Veer, Michael J., Curtis, Joan M., Baldwin, Tracey M., DiDonato, Joseph A., Sexton, Adrienne, McConville, Malcolm J., Handman, Emanuela, Schofield, Louis

“…Leishmania major is an obligate intracellular eukaryotic pathogen of mononuclear phagocytes. Invasive promastigotes gain entry into target cells by…”
Get full text

Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells by Tallant, Thomas, Deb, Amitabha, Kar, Niladri, Lupica, Joseph, de Veer, Michael J, DiDonato, Joseph A

“…Infection of intestinal epithelial cells by pathogenic Salmonella leads to activation of signaling cascades that ultimately initiate the proinflammatory gene…”
Get full text

The WOEST 2 registry by de Veer, A. J. W. M, Bennaghmouch, N, Bor, W. L, Herrman, J. P. R, Vrolix, M, Meuwissen, M, Vandendriessche, T, Adriaenssens, T, de Bruyne, B, Magro, M, Dewilde, W. J. M, ten Berg, J. M

“…BackgroundPatients on oral anticoagulants (OACs) undergoing percutaneous coronary intervention (PCI) also require aspirin and a P2Y12 inhibitor (triple…”
Get full text

Purification and some properties of a membrane-bound aminopeptidase A from Streptococcus cremoris by Exterkate, F.A, Veer, G.J.C.M. de

“…Classifications Services AEM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text